DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Hodi FS, Hwu WJ, Kefford R. et al.
Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab.
J Clin Oncol 2016;
34: 1510-1517
DOI: 10.1200/JCO.2015.64.0391. (PMID: 26951310)
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.